F Cremonini

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
    F Cremonini
    Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA02215, USA
    Aliment Pharmacol Ther 36:437-48. 2012
  2. doi request reprint Evolving concepts in chronic constipation in Europe and elsewhere: not worlds apart
    F Cremonini
    Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Neurogastroenterol Motil 23:693-6. 2011
  3. doi request reprint Rifaximin for the treatment of irritable bowel syndrome
    Filippo Cremonini
    Harvard Medical School, Center for Clinical and Translational research in Gastrointestinal Motility, Beth Israel Deaconess Medical Center, Division of Gastroenterology, 330 Brookline Avenue, Boston, MA 02215, USA
    Expert Opin Pharmacother 13:433-40. 2012
  4. doi request reprint Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation - a double-blind, randomized, placebo-controlled, study
    A J Lembo
    Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center BIDMC, Harvard Medical School, Boston, MA 02215, USA
    Aliment Pharmacol Ther 31:979-90. 2010
  5. doi request reprint Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis
    E J Videlock
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Neurogastroenterol Motil 25:509-20. 2013
  6. pmc Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease
    F Cremonini
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    Aliment Pharmacol Ther 32:29-42. 2010
  7. doi request reprint Meta-analysis: probiotics in antibiotic-associated diarrhoea
    E J Videlock
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    Aliment Pharmacol Ther 35:1355-69. 2012

Collaborators

Detail Information

Publications7

  1. pmc Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
    F Cremonini
    Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA02215, USA
    Aliment Pharmacol Ther 36:437-48. 2012
    ..Patients with irritable bowel syndrome with diarrhoea (IBS-D) experience restriction in daily activities and decreased health-related quality of life (QOL)...
  2. doi request reprint Evolving concepts in chronic constipation in Europe and elsewhere: not worlds apart
    F Cremonini
    Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Neurogastroenterol Motil 23:693-6. 2011
    ....
  3. doi request reprint Rifaximin for the treatment of irritable bowel syndrome
    Filippo Cremonini
    Harvard Medical School, Center for Clinical and Translational research in Gastrointestinal Motility, Beth Israel Deaconess Medical Center, Division of Gastroenterology, 330 Brookline Avenue, Boston, MA 02215, USA
    Expert Opin Pharmacother 13:433-40. 2012
    ..Rifaximin is a nonsystemic antibiotic that has shown efficacy in IBS...
  4. doi request reprint Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation - a double-blind, randomized, placebo-controlled, study
    A J Lembo
    Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center BIDMC, Harvard Medical School, Boston, MA 02215, USA
    Aliment Pharmacol Ther 31:979-90. 2010
    ..Renzapride, a 5-hydroxytryptamine type-4 (5-HT(4)) receptor agonist and 5-HT(3) receptor antagonist, has been proposed as a new treatment of irritable bowel syndrome with constipation (IBS-C)...
  5. doi request reprint Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis
    E J Videlock
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Neurogastroenterol Motil 25:509-20. 2013
    ..Aims of this study are to estimate the prevalence of abnormal findings associated with DD across testing modalities in patients referred for physiological testing for CC...
  6. pmc Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease
    F Cremonini
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    Aliment Pharmacol Ther 32:29-42. 2010
    ..Little is known about the determinants and the circumstances associated with placebo response in the treatment of gastro-oesophageal reflux disease (GERD)...
  7. doi request reprint Meta-analysis: probiotics in antibiotic-associated diarrhoea
    E J Videlock
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    Aliment Pharmacol Ther 35:1355-69. 2012
    ..Diarrhoea is a common occurrence in association with antibiotic administration. Earlier studies and meta-analyses have suggested that probiotic administration reduces the incidence of antibiotic-associated diarrhoea (AAD)...